XL-3156
XL-3156 is a potent, selective, and cross-species cGAS inhibitor. XL-3156 can simultaneously occupy both allosteric and orthosteric sites, and inhibit the interaction and phase separation between cGAS and DNA by stabilizing the closed conformation of the activation loop. XL-3156 can be used in the research of autoimmune diseases, inflammatory conditions and other diseases[1].
Product Specifications
UNSPSC
12352005
Target
Cyclic GMP-AMP Synthase
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.91
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC1=NN(C(O)=C1C(C2=C(N(N=C2C)C3=NC4=CC=CC=C4N3)O)C5=NC=CC=C5)C6=NC7=CC=CC=C7N6
Molecular Formula
C28H23N9O2
Molecular Weight
517.54
References & Citations
[1]Zhao W, et al. De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS. Nat Commun. 2025 Jun 3;16 (1) :5140.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Growth Arrest And DNA Damage Inducible Protein Beta (GADD45B) Antibody
Growth Arrest And DNA Damage Inducible Protein Beta (GADD45B) Antibody
Human Clara Cell Protein 16 (CC16) ELISA Kit
